Chester Wasko, Mary <br/><br/>
Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs.  [electronic resource] 

 -  Arthritis care & research  05 2016 
 - 706-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2151-4658 
<br/><br/><label>Standard No.: </label>10.1002/acr.22722  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Long Term Adverse Effects--chemically induced<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Multivariate Analysis<br/>Prednisone--administration & dosage<br/>Propensity Score<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Risk Factors<br/>Sulfasalazine--administration & dosage<br/>Time Factors<br/>Treatment Outcome